285 related articles for article (PubMed ID: 33299132)
1. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
Liu Y; Baba Y; Ishimoto T; Tsutsuki H; Zhang T; Nomoto D; Okadome K; Yamamura K; Harada K; Eto K; Hiyoshi Y; Iwatsuki M; Nagai Y; Iwagami S; Miyamoto Y; Yoshida N; Komohara Y; Ohmuraya M; Wang X; Ajani JA; Sawa T; Baba H
Br J Cancer; 2021 Mar; 124(5):963-974. PubMed ID: 33299132
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of
Zhang N; Liu Y; Yang H; Liang M; Wang X; Wang M; Kong J; Yuan X; Zhou F
Pathol Oncol Res; 2021; 27():1609846. PubMed ID: 34305476
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.
Nomoto D; Baba Y; Liu Y; Tsutsuki H; Okadome K; Harada K; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Moroishi T; Komohara Y; Sawa T; Baba H
Cancer Lett; 2022 Apr; 530():59-67. PubMed ID: 35033591
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral
Yamamura K; Izumi D; Kandimalla R; Sonohara F; Baba Y; Yoshida N; Kodera Y; Baba H; Goel A
Clin Cancer Res; 2019 Oct; 25(20):6170-6179. PubMed ID: 31358543
[TBL] [Abstract][Full Text] [Related]
5.
Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma.
Guo S; Chen F; Li L; Dou S; Li Q; Huang Y; Li Z; Liu W; Zhang G
J Adv Res; 2024 Jul; 61():165-178. PubMed ID: 37619934
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma.
Li Z; Shi C; Zheng J; Guo Y; Fan T; Zhao H; Jian D; Cheng X; Tang H; Ma J
BMC Microbiol; 2021 Oct; 21(1):301. PubMed ID: 34717543
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
9.
Liang M; Liu Y; Zhang Z; Yang H; Dai N; Zhang N; Sun W; Guo Y; Kong J; Wang X; Wang M; Zhou F
Ann Med; 2022 Dec; 54(1):989-1003. PubMed ID: 35435776
[TBL] [Abstract][Full Text] [Related]
10. High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Yamashita K; Miyata H; Makino T; Masuike Y; Furukawa H; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Morii E; Mori M; Doki Y
Ann Surg Oncol; 2017 Dec; 24(13):4025-4032. PubMed ID: 29022200
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum promotes proliferation in oesophageal squamous cell carcinoma via AHR/CYP1A1 signalling.
Yin H; Zhang J; Zhang H; Li Q; Qiu H; Hong K; Wang W; Xiao Y; Yu B
FEBS J; 2023 Feb; 290(3):837-854. PubMed ID: 36070107
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of Fn-induced high expression of KIR2DL1 in CD8 T lymphocytes in oesophageal squamous cell carcinoma.
Wang X; Liu Y; Lu Y; Chen S; Xing Y; Yang H; Wang X; Zhang Y; Pan T; Li J; Wang M; Zhang N; Liang M; Zhou F
Ann Med; 2022 Dec; 54(1):51-62. PubMed ID: 34935568
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy.
Gao S; Liu Y; Duan X; Liu K; Mohammed M; Gu Z; Ren J; Yakoumatos L; Yuan X; Lu L; Liang S; Li J; Scott DA; Lamont RJ; Zhou F; Wang H
Br J Cancer; 2021 Aug; 125(3):433-444. PubMed ID: 33981017
[TBL] [Abstract][Full Text] [Related]
15. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
16. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.
Yamasaki M; Makino T; Masuzawa T; Kurokawa Y; Miyata H; Takiguchi S; Nakajima K; Fujiwara Y; Matsuura N; Mori M; Doki Y
Br J Cancer; 2011 Feb; 104(4):707-13. PubMed ID: 21206495
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id-1.
Han L; Cui D; Li B; Xu WW; Lam AKY; Chan KT; Zhu Y; Lee NPY; Law SYK; Guan XY; Qin YR; Chan KW; Ma S; Tsao SW; Cheung ALM
Cancer Sci; 2019 Dec; 110(12):3677-3688. PubMed ID: 31646712
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of KCNMA1 facilitates the reversal effect of verapamil on the chemoresistance to cisplatin of esophageal squamous cell carcinoma cells.
Ge N; Yang GS; Zhang TY; Chang N; Kang YH; Zhou Q; Fan PS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1869-1880. PubMed ID: 33660797
[TBL] [Abstract][Full Text] [Related]
19. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
20. Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed.
Meemanage M; Spender LC; Collinson D; Iannetta J; Challapalli P; Turbitt J; Clark C; Baxter M; Murray G; Walsh S; Miedzybrodzka Z; Petty RD
Cancer Chemother Pharmacol; 2021 Mar; 87(3):361-377. PubMed ID: 33169187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
